Cas:62690-13-5 octadecanoic-4,4-d2 acid manufacturer & supplier

Chemical Name:octadecanoic-4,4-d2 acid

CAS.NO:62690-13-5

Synonyms:Bis-<4-decyloxy-phenyl>-acetylen;4,4-dideuterio-octadecanoic acid;4,4-d2-Octadecansaeure;3,3-d2-Octadecansaeure;stearic acid-4d2;4,4′-Didecyloxy-diphenylacetylen

Molecular Formula:C₁₈H₃₄D₂O₂

Molecular Weight:286.49000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:359.4ºC at 760 mmHg

Density:0.894 g/cm3

Index of Refraction:

PSA:37.30000

Exact Mass:286.28400

LogP:6.33250

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Bis-&lt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4,4′-Didecyloxy-diphenylacetylen physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,-acetylen Use and application,3,3-d2-Octadecansaeure technical grade,usp/ep/jp grade.

Related News: Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV) and Severe Acute Respiratory Syndrome (SARS-CoV). A novel coronavirus (nCoV) is a new strain that has not been previously identified in humans. octadecanoic-4,4-d2 acid manufacturer A U.S. Senator, New Jersey Democrat Bob Menendez, called allegations of manufacturing irregularities and records tampering at the Branchburg plant troubling. Menendez has sponsored a bill calling for a non-partisan, independent COVID-19 Commission to examine the U.S. pandemic response, including government contracts with companies. octadecanoic-4,4-d2 acid supplier More than 2,000 new cases were also recorded in the country in the past 24 hours, raising the worldwide total to nearly 14,380, according to Chinese and World Health Organization data. The vast majority of the cases are inside China; about 100 cases have been confirmed in at least 23 other countries. octadecanoic-4,4-d2 acid vendor This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. octadecanoic-4,4-d2 acid factory This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care.